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Considering the enormous power of gene targeting for dissecting
and analysing biological phenomena1, it is remarkable that, for
more than a decade, application of this technology has been
restricted to either relatively simple organisms (the bacteria and
fungi) or the mouse. A pair of recent studies open up new vistas in
their demonstration of gene targeting in Drosophila melanogaster2
and sheep3. The strategies of these different studies are conspicu-
ously different. In Drosophila, the gene-targeting reaction—
homologous recombination between an exogenous modified
DNA sequence and the cognate, endogenous genomic sequence—
occurs in the intact animal (Fig. 1). In contrast, transgenic sheep
were generated though a targeting reaction in cultured fetal
fibroblasts (Fig. 2).
The method developed by
Rong and Golic2 for generating
targeted mutations in
Drosophila is composed of three
parts: (i) a transgene that
expresses the site-specific yeast
recombinase Flp; (ii) a trans-
gene that expresses the site-spe-
cific endonuclease I-SceI; and
(iii) a transgenic donor con-
struct that contains the recog-
nition sites (FRT and I-SceI) for
both enzymes, in addition to
the modified, exogenous DNA
sequences to be used to mutate
the endogenous cognate chro-
mosomal sequence (Fig. 1). The
Flp recombination target (FRT) sites flank the exogenous DNA
sequences, and the I-SceI site is within the region of homology
between the exogenous and endogenous DNA sequences. The
transgenes encoding the Flp-recombinase and the I-SceI-endonu-
clease are under the control of a heat-inducible promoter.
Flies containing each transgene were constructed separately and
then crossed to bring all three transgenes together in the progeny.
Heat shock of the triple-transgenic flies activates Flp recombinase
which, in turn, triggers the release of the donor fragment from the
chromosome as a circle. The circular fragment is then cleaved by
the I-SceI endonuclease. The linearized DNA fragment serves as a
substrate for the endogenous homologous recombination machin-
ery of the cell, finds the cognate sequence on the chromosome, and
engages in a homologous recombination reaction that transfers the
desired modification to the endogenous gene.
Size matters
The homologous-recombination machinery in Drosophila seems
to be much more mouse-like than yeast-like4,5. For example,
optimal targeting frequencies in Drosophila and mice require
extensive DNA sequence homology between the donor DNA
fragment and the recipient chromosomal sequence, rather than
the short stretches of homology (of approximately 100 bp) that
suffice in yeast. The original targeting experiments reported by
Rong and Golic2 used 8 kb of homology between the exogenous
and endogenous DNA sequences. Reducing the homology to 2.5
kb reduced the targeting frequency by more than tenfold6.
Homologous stretches of 5 kb yielded an intermediate targeting
frequency. Such sensitivity of
the targeting frequency to the
extent of homology between
the targeting construct and the
endogenous chromosomal
sequence is very similar to that
observed in mammalian cells,
including mouse embryonic
stem (ES) cells7,8.
In both yeast and mam-
malian cells, linear DNA mole-
cules are more effective
substrates for gene-targeting
reactions than are circular mol-
ecules5,9,10. For this reason,
Rong and Golic went to great
lengths to generate linear DNA
donor molecules for their in
vivo targeting reaction. They achieved this goal by using the site-
specific endonuclease I-SceI. A double-strand break within the
region of homology was introduced to favour so-called ‘ends in’
homologous recombination reactions, which we have called
‘insertion’ reactions7 (Fig. 1). Despite the use of this type of DNA
donor substrate, Rong and Golic observed (among their prod-
ucts of recombination) equal numbers of molecules that may
have been generated by ‘ends in’ and ‘ends out’, or what we would
call ‘insertion’ and ‘replacement’, reactions7. This suggests that
the location of the cleavage site within the donor construct may
not be critical and that, as in mammalian cells, ‘insertion’ and
‘replacement’ reactions are equally effective7,11.
The ability to generate mice with targeted mutations has been
dependent on the use of the ES cell as a vehicle to transmit the
mutation to the mouse germ line. This is because the frequency
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of homologous recombination between the targeting vector and
the target locus is low, relative to the frequency of random inser-
tions of the targeting vector into the host cell genome. It is there-
fore impractical to generate mice with targeted mutations by
injecting the targeting vector directly into fertilized eggs. The
main obstacle to generating transgenic individuals of other
mammalian species is due to a failure to obtain cells capable of
contributing to the formation of the germ line. But with the birth
of Dolly12, a cloned sheep generated by nuclear transfer of a
somatic cell nucleus into an enucleated egg, an alternative route
to gene-targeted mammals was also born. The targeting reaction
can be carried out in any karyotypically stable, somatic cell that
can be cultured in vitro. Particularly attractive for this purpose
are fetal fibroblasts, as they are easy to obtain and can be main-
tained in culture for many passages without compromising their
ability to generate cloned animals by nuclear transfer13. Once a
successful targeting event has been identified in these cultured
cells, its nucleus is transferred to an enucleated egg of the same
species, creating an embryo. The embryo is then transferred to
the uterus of a foster mother and allowed to come to term, gener-
ating a live animal with a targeted mutation (Fig. 1).
The study by McCreath et al.3 describes the first successful
application of this procedure to generate sheep with targeted
mutations. To ensure a high targeting frequency, McCreath et al.3
chose to introduce their targeted modification into a gene that
was known to be expressed at high levels in cultured fibroblasts,
the ovine I procollagen (COLIAI) gene. To enrich for cells con-
taining the targeted mutation (over cells containing random
insertions of the targeting vector), they used a selectable gene,
neor, that lacked its own promoter. Activation of the selectable
gene therefore relied on integration of the vector adjacent to a
functional genomic promoter. Most random insertions into the
genome would not be predicted to provide a suitable promoter to
the promoterless neor gene. McCreath et al. also demonstrated
that the COLIAI locus was a suitable environment to allow a
transgene, driven by a promoter specific to mammary epithe-
lium, to be specifically expressed in that tissue, even though
COLIAI itself is not actively expressed in mammary epithelium.
These experiments are of particular interest to drug companies
that are exploring the potential of using livestock to produce
pharmaceuticals in their milk.
Only further experimentation will determine whether genes
other than COLIAI are suitable targets for genomic modification
using modified fibroblasts as nuclear donors. In mouse ES cells,
any gene can be readily modified if appropriate enrichment tech-
niques are used14. Our experience further suggests that if the
experiments are carried out appropriately, including the use of
isogenic DNA and optimized selection procedures, most mam-
malian cells in culture have roughly equivalent capacities to
mediate homologous recombination between exogenous and
endogenous DNA sequences. So most genes should also serve as
suitable substrates for targeted modification using the ‘fibroblast’
system described by MacCreath et al.
With the mouse/ES cell system, necessary intermediates in the
process of generating mice with targeted mutations are chimaeric
mice. These mice are composed of a mixture of cells derived from
the targeted ES cells and the recipient blastocyst. As chimaeric
mice are not composed entirely of cells containing the targeted
mutation, they may not have the full set of properties associated
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Fig. 1 Gene target ing in Drosophila. The gene-target ing protocol described by
Rong and Golic2 occurs within the intact  fl y. ‘FRT’ and ‘S’ denote the recognit ion
sequences for the yeast  Flp-recombinase and the I-SceI-site-specifi c endonucle-
ase, respect ively. Following heat  shock, the donor f ragment is released f rom the
chromosome as a DNA circle, which is then cleaved by the I-SceI endonuclease.
The linearized f ragment then serves as a substrate for homologous recombina-
















Fig. 2 Gene target ing in sheep. McCreath et  al.3 have generated sheep with
targeted modifi cat ions in the ovine gene encoding procollagen-1. The target -
ing vector was int roduced into cultured primary fetal fi broblasts. Following the
ident ifi cat ion of  cells with the desired targeted modifi cat ion, its nucleus was
t ransferred to an enucleated egg, creat ing an embryo. The embryo was then
t ransferred to the uterus of  a foster mother and allowed to come to term. This
procedure generated live lambs with a targeted mutat ion.
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with mice in which every cell contains the targeted mutation.
Such mice are generated by breeding the chimaeric mouse to a
suitable mate. An advantage of the fibroblast-nuclear transfer
method for generating animals with targeted mutations is that it
bypasses the need to generate chimaeric intermediates. This rep-
resents a major savings in time and money when it comes to gen-
erating livestock with a comparatively lengthy generation time
(and hence substantive fees for board and lodging).
Are there sufficient advantages to the fibroblast/nuclear trans-
fer system to use it as the preferred method for generating mice
with targeted mutations? It seems not, as the efficiency of gener-
ating viable offspring in mice by the fibroblast/nuclear transfer
method does not match that of the chimaera method. The cause
of extensive pre- and postnatal mortality of cloned animals has
yet to be identified, although it has been proposed that a disrup-
tion of complex changes in the patterns of genomic demethyla-
tion and methylation may be to blame.
Functional genomics
Most of the Drosophila genome is now sequenced15. Although the
analysis is far from complete, current estimates centre around a
complement of 14,000 to 15,000 genes. The functions of most of
these have yet to be determined. Until very recently, the most rea-
sonable method for generating a comprehensive collection of
mutants in Drosophila was by insertional mutagenesis using P-
elements16. But despite extensive efforts, mutant collections
cover only one-third of the Drosophila genes. The limitation of
this approach is largely due to limited sequence specificity of the
P-element insertion sites—and not all P-element–mediated
insertions generate null mutations.
As will have escaped the attention of few, over the past several
months estimates of the number of mammalian genes have varied
over a wide range—from 40,000 to over 100,000 genes. By the time
the mouse genome is complete (in about 3 to 4 years’ time), there
may be as many as 20,000 mouse lines with targeted disruption of
different genes. This early milestone will have been accomplished in
the absence of any coordinated program. There is an ongoing
debate on whether insertional mutagenesis17 or gene targeting is
the better means of generating mouse mutants. I strongly favour the
latter. The greatest investment of time and money in new mouse
mutants is not in their generation, but their subsequent analysis.
The latter exceeds the former by factors of 20 or more. The preci-
sion afforded by gene targeting, which takes advantage of estab-
lished DNA sequence, allows construction of alleles that favour
analysis. With a single construct, multiple alleles can be generated at
a specified locus: null alleles, conditional alleles and reporter genes
that facilitate visualization of gene activity. As with yeast, the advan-
tages of targeted alleles in facilitating the analysis of the mutant phe-
notype (compared with mutant alleles generated by random
insertion) far outweigh their initially higher up-front costs.
On application
The extension of gene targeting to Drosophila and sheep will have
different impacts on life as we know it. Gene targeting in
Drosophila, as in mice, will be used primarily as a basic research
tool. It will be used to generate mutant alleles that cannot readily
be obtained by genetic screens or by P-element–based mutagenic
protocols. The impact of gene targeting in sheep, on the other
hand, will be primarily commercial. The technology will be used
to improve other livestock, the first examples of which will prob-
ably be cattle resistant to specific pathogens such as scrapie. The
pressing need for organs suitable for human transplantation has
led to the suggestion that organs from domestic animals, such as
the pig, might be used instead of human organs. Such approaches
are not presently feasible because of the rapidity with which pig
tissue would be rejected by the human immune system. Gene tar-
geting offers the possibility of modifying pig tissue so that it is
better tolerated by our immune system.
Drosophila is one of the most intensively studied model organ-
isms and the addition of gene targeting to its repertoire of tricks
will greatly enhance its usefulness. Similarly, the use of gene tar-
geting in sheep and other livestock will find many uses. Plants are
conspicuously absent from the ‘gene-targeting’ list. This is partic-
ularly surprising because an efficient means of producing trans-
genic plants has been available for a number of years. And intact
plants can be generated from cells maintained in culture. The lat-
ter property provides the opportunity to fashion gene-targeting
strategies based on a cell-culture approach, or by using an in vivo
strategy such as that used by Rong and Golic2. Regardless of bio-
logical context, gene targeting permits a systematic dissection of
the most complex of biological processes, and so the extension of
gene targeting to Drosophila and sheep is a welcome advance.
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